Colm G. Hanratty, MD

Subintimal TRAnscatheter Withdrawal (STRAW) of Hematomas Compressing the Distal True Lumen: A Novel Technique to Facilitate Distal Reentry During Recanalization of Chronic Total Occlusion (CTO)

01/09/2015

Colm G. Hanratty , MD;

Ranil de Silva , MD, PhD;

Alistair C. Lindsay , MD, PhD;

J. Aaron Grantham , MD;

Elliot J. Smith , MD;

Carlo Di Mario , MD, PhD, FESC, FACC, FRCP;

James C. Spratt , MD, FRCP, BSc, MBChB;

The development of a large hematoma impairing visualization of the distal true lumen is a recognized complication of antegrade recanalization of chronic total occlusions, often forcing the operator to abort the procedure or switch to a...

The development of a large...

01/09/2015

Journal of Invasive Cardiology

Original Contribution

One-Year Clinical Outcomes of the Hybrid CTO Revascularization Strategy After Hospital Discharge: A Subanalysis of the Multicenter RECHARGE Registry

11/15/2017

Alexander J. Chase , MBBCh, PhD, MBBS, MD;

Erwan Bressollette , MD;

Dave Smith , BM, MD;

William H.T. Smith , MB, MA, MRCP, PhD, FRCP;

John Irving , MD;

Simon J. Walsh , MD;

Joseph "Jo" Dens , MD, PhD;

Andrew Ladwiniec , MD;

Margaret B. McEntegart , MD, PhD, BSc(Hons), MBChB;

Alexandre Avran , MD, PhD;

Paul Knaapen , MD, PhD;

Benjamin Faurie , MD, PhD;

Pierfrancesco Agostoni , MD, PhD;

Alun A. Harcombe , MD, MRCP;

James C. Spratt , MD, FRCP, BSc, MBChB;

Colm G. Hanratty , MD;

Peter Kayaert , PhD, MD;

Joren Maeremans , MSc;

The hybrid algorithm and contemporary wiring and dissection re-entry techniques can potentially improve long-term outcomes after CTO-PCI. This study assessed the long-term clinical outcomes of the hybrid CTO practice, when applied by...

The hybrid algorithm and...

11/15/2017

Journal of Invasive Cardiology

Original Contribution

Initial Experience of Bioabsorbable Polymer Everolimus-Eluting Synergy Stents in High-Risk Patients Undergoing Complex Percutaneous Coronary Intervention With Early Discontinuation of Dual-Antiplatelet Therapy

12/15/2016

Colm G. Hanratty , MD;

Simon J. Walsh , MD;

Rebecca L. Noad , MB, PhD;

Synergy stents (Boston Scientific) allow for early cessation of DAPT. This study assessed those in our unit who underwent PCI with a Synergy stent to examine a minimum of 6 months of clinical outcomes after early discontinuation of DAPT.

Synergy stents (Boston...

12/15/2016

Journal of Invasive Cardiology

Original Contribution

Efficacy and Safety of Novel NovaCross Microcatheter for Chronic Total Occlusions: First-in-Human Study

02/29/2016

Abid R. Assali , MD;

Ran Kornowski , MD;

Dariusz Dudek , MD, PhD, FESC;

Colm G. Hanratty , MD;

Leszek Bryniarski , MD, PhD, FESC;

Simon J. Walsh , MD;

Haim Danenberg , MD;

Chaim Lotan , MD;

Piotr Wilkołek , MD, PhD;

The aim of this first-in-human (FIH) study was to evaluate the efficacy and safety of the novel NovaCross microcatheter system in eligible consecutive patients with chronic total occlusion (CTO).

The aim of this first-in-human...

02/29/2016

Journal of Invasive Cardiology